{"nct_id":"NCT00750698","title":"A Phase 2 Exploratory Study of Erlotinib and SNDX-275 in Participants With Non-small Cell Lung Carcinoma Who Are Progressing on Erlotinib","status":"TERMINATED","status_verified_date":"2023-07","start_date":"2008-08","start_date_type":null,"primary_completion_date":"2010-05","primary_completion_date_type":"ACTUAL","completion_date":"2010-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNDX"]}